Amwill Health Care (AMWILL) | Financial Analysis & Statements
Amwill Health Care Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2024Income Metrics
Revenue
81.6M
Gross Profit
58.1M
71.21%
Operating Income
18.9M
23.15%
Net Income
15.3M
18.78%
Balance Sheet Metrics
Total Assets
714.8M
Total Liabilities
22.6M
Shareholders Equity
692.2M
Debt to Equity
0.03
Cash Flow Metrics
Operating Cash Flow
-24.2M
Free Cash Flow
-52.7M
Revenue & Profitability Trend
Quarter Income Flow Mar 31, 2024
Annual Income Flow
2025
Amwill Health Care Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 405.8M | 439.5M | 301.7M | 276.1M | 180.0M |
| Cost of Goods Sold | 115.1M | 120.3M | 90.7M | 87.7M | 80.3M |
| Gross Profit | 290.7M | 319.2M | 211.0M | 188.4M | 99.7M |
| Gross Margin % | 71.6% | 72.6% | 69.9% | 68.2% | 55.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 43.6M | 45.8M | 48.2M | 53.7M | 47.8M |
| Other Operating Expenses | 54.1M | 49.7M | 43.4M | 28.5M | 23.4M |
| Total Operating Expenses | 97.7M | 95.6M | 91.6M | 82.2M | 71.2M |
| Operating Income | 113.3M | 164.7M | 41.5M | 38.3M | -10.3M |
| Operating Margin % | 27.9% | 37.5% | 13.8% | 13.9% | -5.7% |
| Non-Operating Items | |||||
| Interest Income | 7.1M | 3.1M | 1.2M | 22.0K | 0 |
| Interest Expense | - | - | - | - | - |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 119.0M | 167.6M | 41.7M | 33.3M | -10.3M |
| Income Tax | 11.7M | 42.6M | 10.6M | 7.6M | -333.0K |
| Effective Tax Rate % | 9.9% | 25.4% | 25.4% | 22.8% | 0.0% |
| Net Income | 107.3M | 125.0M | 31.1M | 25.7M | -10.0M |
| Net Margin % | 26.4% | 28.4% | 10.3% | 9.3% | -5.5% |
| Key Metrics | |||||
| EBITDA | 119.1M | 167.3M | 44.9M | 46.6M | -10.2M |
| EPS (Basic) | ₹6.63 | ₹6.25 | ₹1.56 | ₹1.29 | ₹-0.50 |
| EPS (Diluted) | ₹6.63 | ₹6.25 | ₹1.56 | ₹1.29 | ₹-0.50 |
| Basic Shares Outstanding | 16179104 | 20003600 | 20003600 | 20003600 | 20003600 |
| Diluted Shares Outstanding | 16179104 | 20003600 | 20003600 | 20003600 | 20003600 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Amwill Health Care Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 30.7M | 32.8M | 68.5M | 24.1M | 488.0K |
| Short-term Investments | - | - | 10.1M | - | - |
| Accounts Receivable | 167.2M | 129.6M | 12.3M | 8.8M | 44.1M |
| Inventory | 5.5M | 4.9M | 31.8M | 20.6M | 25.0M |
| Other Current Assets | 1.0K | 3.5M | - | - | - |
| Total Current Assets | 220.6M | 174.6M | 113.8M | 56.0M | 72.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 122.0K | 82.0K | 82.0K | 82.0K | 82.0K |
| Goodwill | 2.5M | 2.4M | 309.0K | 563.0K | 802.0K |
| Intangible Assets | 2.5M | 2.4M | 309.0K | 563.0K | 802.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 2.0K | - | 2.0K | -2.0K | - |
| Total Non-Current Assets | 494.2M | 15.2M | 10.1M | 9.9M | 10.6M |
| Total Assets | 714.8M | 189.8M | 123.9M | 65.9M | 82.9M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 11.1M | 2.9M | 51.8M | 24.3M | 50.7M |
| Short-term Debt | - | 0 | 350.0K | 1.2M | 1.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 204.0K | 30.0K | 27.0K | 333.0K | 6.2M |
| Total Current Liabilities | 19.9M | 15.3M | 75.2M | 49.5M | 92.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | - | - | - | - | - |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 2.8M | 2.9M | 2.7M | 1.4M | 851.0K |
| Total Liabilities | 22.6M | 18.2M | 77.9M | 51.0M | 93.8M |
| Equity | |||||
| Common Stock | 200.0M | 500.0K | 300.0K | 300.0K | 300.0K |
| Retained Earnings | 122.9M | 171.1M | 45.7M | 14.6M | -11.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 692.2M | 171.6M | 46.0M | 14.9M | -10.9M |
| Key Metrics | |||||
| Total Debt | 0 | 0 | 350.0K | 1.2M | 1.2M |
| Working Capital | 200.8M | 159.3M | 38.6M | 6.4M | -20.6M |
Balance Sheet Composition
Amwill Health Care Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 119.0M | 167.6M | 41.7M | 33.3M | -10.3M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -53.8M | -109.4M | -13.8M | 28.7M | -37.6M |
| Operating Cash Flow | 58.2M | 55.2M | 26.8M | 62.1M | -47.9M |
| Investing Activities | |||||
| Capital Expenditures | -7.2M | -8.3M | -3.1M | -607.0K | -8.0M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -7.2M | -8.3M | -3.1M | -607.0K | -8.0M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | 0 | -350.0K | -1.1M | -66.0K | -45.0K |
| Financing Cash Flow | 488.8M | -500.0K | -2.0M | -66.0K | 716.0K |
| Free Cash Flow | 48.5M | -39.5M | 44.8M | 29.1M | -7.3M |
| Net Change in Cash | 539.8M | 46.3M | 21.6M | 61.4M | -55.2M |
Cash Flow Trend
Amwill Health Care Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
8.73
Price to Book
0.96
Price to Sales
1.83
Profitability Ratios
Profit Margin
20.93%
Operating Margin
18.23%
Return on Equity
15.50%
Return on Assets
15.01%
Financial Health
Current Ratio
7.33
Debt to Equity
0.00
Per Share Data
EPS (TTM)
₹4.04
Book Value per Share
₹36.60
Revenue per Share
₹21.03
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| AMWILL | 669.9M | 8.73 | 0.96 | 15.50% | 20.93% | 0.00 |
| Entero Healthcare | 54.7B | 48.93 | 3.11 | 5.36% | 1.87% | 24.63 |
| NOVELIX | 1.2B | 48.76 | 3.10 | 0.48% | 1.41% | 0.00 |
| Royal Sense | 924.5M | 14.61 | 2.60 | 28.62% | 9.63% | 19.41 |
| Trimurthi | 500.4M | 102.35 | - | 0.00% | 3.73% | - |
| Welcure Drugs | 370.8M | 1.30 | 0.28 | 2.12% | 12.21% | 91.72 |
Financial data is updated regularly. All figures are in the company's reporting currency.



